TrialThe Lancet. Respiratory medicine2014

Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials.

Alan F Barker et al.PubMed ↗Publisher ↗

No numbers read from the abstract.